News

Tissue Regenix Group Expects Positive First-Half Earnings

1 Mins read

London, UK – Tissue Regenix Group, a leading medical-devices company, has announced that it is on track to meet its targets for 2023. The company anticipates that its adjusted earnings for the first half of the year will be positive following a significant increase in revenue.

With revenue estimated at approximately $14.1 million for the six months ending June 30, Tissue Regenix Group has achieved a record high and a notable 19% year-on-year growth.

Moreover, the company expects to report positive adjusted earnings before interest, taxes, depreciation, and amortization (Ebitda) for the period. This follows their achievement of adjusted Ebitda profitability in the final quarter of 2022.

“We are optimistic about our future prospects and remain committed to our growth objectives,” stated Chief Executive Daniel Lee confidently. Adding further assurance, he emphasized that the company has ample financial resources to support its plans.

Tissue Regenix Group’s anticipated success in the first half of the year sets a positive trajectory for the remainder of 2023 and beyond.

Related posts
News

Bitcoin Price Stumbles to $112,301 Ahead of Powell's Jackson Hole Speech - Tekedia

3 Mins read
The Bitcoin price edged lower on Thursday, slipping to $112,301 over the past 24 hours. The world’s largest cryptocurrency is now trading…
News

Brisk Pak-US engagement - Pakistan Observer

1 Mins read
US Secretary of State Marco Rubio has said Washington looked forward to exploring cooperation with Pakistan on critical minerals and hydrocarbons. In…
News

Form 13G TrueCar For: 14 August By Investing.com

1 Mins read
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment…

Leave a Reply

Your email address will not be published. Required fields are marked *